Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy

Fig. 3

In vitro effect of metformin and CR treatments on cell viability and metabolism: Cell viability measured by MTS assay after 72 h of treatment with 2 mM of metformin (MET) and 50% of caloric restriction (CR) in KRASG12D (A) and KRASG12D/LKB1del (B) cell lines. One-way ANOVA was used for statistical analysis (**p < 0.01, *** p < 0.001). Error bars indicate SD. Seahorse XF Real-Time Assay was done after 24 h of treatment with 2 mM of metformin (MET) and 50% caloric restriction (CR) in KRASG12D (C) and KRASG12D/LKB1del (D) cell lines. Two-way ANOVA was used for statistical analysis (* p < 0.05, **p < 0.01, *** p < 0.001). Error bars indicate SD

Back to article page